Patients receiving enterai tube feeding are often encountered in the ward environment of an acute care setting. Patients may receive enterai tube feed through tubes intended for short-term feeding, or they may have a long-term feeding tube in situ. This article aims to provide a practical overview of feeding solutions and administration to enable nursing sta£f to understand prescribed regimens and provide patients with optimum care.
settings. Wards should make provisions to monitor and document weight changes, which will help in the monitoring of most patients. Hoist or bed scales are an expensive but useful investment. The identification of a 'weighing day', when the wards are less busy, may also help establish nutritional moiiitoring as a weekly routine. However, there may be circumstances where such weight measurements are impractical as a result of the patient's illness. In such circumstances, the mid upper arm circumference (MUAC), can be used as an alternative. This is a simple measurement taken with a tape measure around the subject's upper arm. A measurement of less than 23.5 cm indicates that body mass index (BMI) is likely to be less than 20 kg/m^.
Similarly, for patients who cannot be measured, and who do not know or cannot report their height, an estimate of height from ulria length can be used. Using a tape measure, a measurement in centimetres from the olecranon process of the elbow to the styloid process ofthe wrist can be used with the tables provided in the Malnutrition Universal Screening Tool (MUST) toolkit to arrive at an estimate, in metres and centimetres, of a patient's height.
It is obvious fi'om these two methods that, \vhereas the ulna length gives a good estimate of height to use in calculations of BMI, and is therefore a good alternative to an actual measurement of height, the MUAC gives an indication of a low BMI only, and should therefore not be routinely used to replace monitoring of weight for those patients for whom weighing is not clinically contraindicated. The full MUST package, including downloadable charts, is available from the British Association for Parenteral and Enterai Nutrition website (http://www.bapen.org.uk/must_tool.htm]).
Any patient identified as malnourished, or at risk of becoming malnourished, should be considered for nutritional support. Patients with any of the following characteristics, either on initial screening or at any time during hospital admission, should be considered for dietary support:
•A BMI of less than 18.5kg/m2 • Unintentional weight loss greater than 10% within the last 3-6 months • A BMI of less than 20kg/m2 and unintentional weight loss greater than 5% within the last 3-6 months • Patients who have had little or nothing to eat for 5 days or more and/or are hkely to eat little or nothing in the next 5 days or more, such as patients recovering from complicated surgery • Patients with poor absorptive capacity, high nutrient losses or increased requirements, such as the critically ill (NICE, 2006) .
Nutritional support may include oral dietary support, in the form of a fortified menu, assistance at meal times (if required), additional snacks and nutritious drinks. Alternatively, oral nutrition supplements such as sip feeds may be used.Where these measures fail and nutritional status remains compromised the patient should be considered for ETF. Equally, patients with a compromised swallow or dysphagia, for whom oral nutrition support may not be appropriate, should also be considered for ETF.
ETF solutions
ETF solutions come in a variety of different formulations (see Table 1 ), which will normally be prescribed by a dietician, following a thorough assessment of the patient's nutritional requirements, diagnosis, gastrointestinal function, age, body weight and other factors, such as time available in the 24-hour period to administer the feed and fluid prescription, and possible breaks required to administer medications.
ETF solutions are derived from a protein source (normally cow's milk protein, whey or soya), a carbohydrate source (normally maltodextrin, glucose, sucrose, or corn syrup solids) and a fat source (normally vegetable oils) (Thomas, 2001) . The solutions provide 4-7.5 g of protein per 100 ml of feed (British Dietetic Association, 2005) .The solutions have added vitamins and minerals and are nutritionally complete for these micronutrients in 1500 kcal, with the exception of the lowkcal feeds and some of the specialist feeding solutions. Some products have added fibre, while others remain fibre-free. It is generally regarded that the use of ETF solutions with added fibre blends may have a beneficial effect on the maintenance of healthy bowel movements, particularly in terms of preventing constipation, by miinicking a normal diet (Murphy, 2001) , thus making these the solution of choice. The benefits of ETF solutions with added fibre on preventing diarrhoea are less clear (Stroud et al, 2003) , although the manufacturers claim various fibre blends may prevent diarrhoea through fermentation of the fibre blend in the gut (Green, 2001) .
Nutritional requirements and patient monitoring
Basehne nutritional requirements should be calculated at the start of ETF and used as the goal for nutritional support. Concerns have been raised in recent years over energy and protein prescription when providing artificial nutritional support, as adverse outcomes, such as electrolyte disturbances, cardiac failure and even death, have been documented in acutely ill and severely malnourished patients (NICE, 2006) .
The term 'refeeding syndrome' is used to describe a series of metabolic abnormalities in patients who are malnourished or have been starved and are then subsequently re-fed with large doses of energy and/or protein. For those patients who are severely ill and/or malnourished, and therefore at risk of developing refeeding syndrome, energy prescription should be provided at 50% of estimated requirements and increased Nutritionally complete feeds in 1000ml and 1.0-1.2 kcal/ml. Designed fbr patients with low kcal requirements, such as in those with iimlted mobility. Manufactured from partially hydrolysed, to produce a protein base of di-and tri-peptides. rather than whole protein. Commonly used in patients with bowei disease affecting absorption when standard feeds are not toierated. such as infiammatoiy bowel diseases. Semi-elemental feeds can also be useful in frail patients suffering/recovering from Clostridium difflciie. to reduce uncomfortable diarrhoea with subsequent skin excoriation. (NICE, 2006) . It may also be necessary to provide additional micronutrient supplements, particularly the B vitamin group, which are cofactors in many biochemical processes related to energy metabolism, while the patient's ETF prescription is being increased to meet estimated requirements. The Guideline Development Committee of NICE (2006) recommends providing the following in adults who are not severely ill or at risk of refeeding syndrome:
• 25-35 kcal/kg/day total energy (kcal) • 0.8-1.5 g protein/kg/day • 30-35 ml fluid/kg/day (plus additional fluid to replace fluids lost through fistulas or drains) • Adequate micronutrients should also be provided, for example, through the use of the commercially prepared ETF solutions {Table 1).
Methods of administering ETF
ETF is usually administered via an enteral feeding pump or as a bolus feed using a syringe. Enteral feeding pumps are available on loan by enteral feeding solution manufacturers and can be used to deliver feed continuously throughout a 24-hour period, or for a reduced number of hours each day, such as 16-18 hours. The pack of feed will be attached to the patient's feeding tube by way of a giving set, which is then passed through the feeding pump. Giving sets are specific to the manufacturers feeding solutions and feeding pumps and are not normally interchangeable.
Pump feeding
More commonly in both the inpatient and home ETF setting, patients will receive intermittent ETF, where their entire feed prescription is adirdnistered over a period of 16-20 hours, rather than receiving continuous pump feeding for the fuU 24-hour period. This was both to provide patients with a break, but also as it was thought that a 4-hour period in every 24 hours where no feed nor water was administered allowed the stomach to return to an acidic pH, thus preventing bacterial translocation and gastroenteritis (Thomas, 2001 ). On more recent review of the literature, NICE (2006) concluded that there was no significant difi^rence in either the rate of gastric colonization nor in gastric pH in patients receiving 24-hour pump feeding versus those receiving pump feeding for 16-18 hours. This would therefore suggest that the choice of whether to feed continuously over 24 hours, or whether to administer the feed prescription over a shorter time period, will ultimately come down to patient choice and/or practical aspects at ward level, rather than any clinical benefit of a shorter feeding time. NICE (2006) also concluded that for patients in the intensive care unit (ICU), metabolic stabihty, stable blood glucose levels and possible reduced gastric emptying favoured continuous pump feeding, as a continuous infiasion could both stabilize blood glucose levels and prevent high gastric residues resulting in aspiration. The patient will be prescribed a set volume of feed to be administered at a given rate via the feeding pump. A feeding start time will usually be included in the instructions. It is essential to record the name of the feed used, the volume pack selected, the feeding rate and the start date and time in the patient's records. This constitutes not only the nursing records of care given, but also helps colleagues determine how much of the daily feed prescription has been administered for those patients whose feeding regimens are administered through more than one ward shift.
Bolus feeding
Another method of administering ETF is by means of bolus feeding through a syringe or by using the enteral feeding pump intermittently set at a higher rate than that used for a continuous or intermittent feeding regimen. This method is not commonly used in the acute care setting but can be helpful for patients who pull at nasogastric tubes (NICE, 2006) . It is generally not advisable to use this method when feeding into the bowel as the bowel does not have the reservoir capacity of the stomach.
The ETF prescription for a bolus feeding regimen may specify the use of cartons of sip feed as the feeding solution or measured quantities of enteral feeding solution -normally 250-500 ml. When administering a bolus feed through a syringe, packs of enteral feed should be opened using a special bolus adaptor with an internal spike, similar to a giving set spike, rather than scissors or other sharp implements, to reduce the risk of infection (Infection Control Nurses Association [ICNA], 2003) . The prescribed amount of feed should be decanted into a clean or sterile container and drawn up using a 50 ml syringe indicated for enteral feeding. Alternately, the syringe can be attached directly to the patient's feeding tube with the barrel removed and the clamp closed on the tube. The feeding solution can then be poured directly into the barrel of the syringe, the clamp released to allow the feed to flow through the tube under gravity, the clamp closed and the procedure repeated until the prescribed amount of feed has been delivered. Syringes should not be inserted directly into packs of feed if further administrations are intended from the same pack.
It is generally recommended that patients receive ETF in an upright or semi-upright position and remain in this position for at least 30 minutes after completing the feeding prescription to reduce the risk of reflux and/or aspiration. This is particularly important for patients receiving ETF by the bolus feeding method, for patients receiving feed into the stomach and for those with a history of aspiration. Upright and senii-upright positioning may be contraindicated in certain patient groups such as ICU patients or patients on orthopaedic wards.
Fiushing the feeding tube
All feeding tubes should be flushed with at least 30 ml of water before and after administration of feeds or boluses, and before and after administration of medications (Dougherty and Lister, 2004) For patients with feeding tubes ending in the stomach -percutaneous endoscopic gastrostomy (PEG) tubes, radiologically inserted gastrostomy (RIG) tubes, balloon gastrostomy and nasogastric (NG) tubes -it should be adequate to flush the tube with freshly drawn tap water each time water is administered (NICE, 2003) . Wards may prefer to use sterile water from a freshly opened container each time the patient is due a water flush. For patients who are immunocomproniised or for those with a feeding tube that ends in the bowel -jejunostomy tubes, percutaneous endoscopic gastrostomy tubes with a jejunal extension (PEGJ tubes) and nasojejunal (NJ) tubes -either cooled, freshly boiled water should be used each time the tube requires flushing, or sterile water from a freshly opened container (Department of Health, 2006) , to prevent the risk of infection from the water source. It is w^orth noting that bottles of sterile water should never be accessed using a nonsterile syringe and re-used later.
ETF care
There is a wide range of feeding available to provide ETF, all with slightly difl^erent indications. Short-term feeding tubes can either be placed at the patient's bedside (NG tubes) or in the radiology department under radiological guidance (nasojejunal [NJ] tubes). More long-term feeding tubes will either be placed in the endoscopy suite (PEG tubes), under radiological guidance (RIG tubes) or under surgical laparotomy (i.e. jejunostomy tubes).
NG tubes
NG tubes are placed at the patient's bedside by skilled nursing or medical staff. NG tubes are indicated for shortterm feeding on a trial basis or when a return to oral intake is anticipated. The tubes are occasionally used for long-term feeding if the patient's clinical condition suggests a more invasive procedure and insertion of a long-term feeding tube will not be tolerated. See Table 2 for information on   Table 2 . Testing the position of nasogastric feeding tubes Methods that should be used I Measuring the pH of cispirate using pH indicator strips with 0.5 gradations or paper with a range of 0-6 or 1-11. lt is important that the resulting coiour change is easily distinguishable, particularly between the pH 5 and 6 range > Radiography
Methods that should not be used • Auscultation of air insufflated through the feeding tube ('whoosh' test) • Testing the acidity/alkalinity of aspirate using blue litmus paper • Interpreting absence of respiratory distress as an indicator of correct positioning • Monitoring bubbiing at the end of the tube • Observing the appearance of feeding tube aspirate
Adapted from: National Patient Safety Agency (2005) testing the position of NG tubes. Although fairly easy to place by skilled nursing staff, NG tubes require replacement every 6 weeks to 3 months, depending on manufacturer, and they can also become dislodged. Following several deaths as a result of the positioning of NG tubes in patients' lungs rather than the stomach, the National Patient Safety Agency (2005) issued guidance on testing the position of NG tubes. All NHS Trusts should adopt the recommendations in this document, as summarized in Table 3 .
Nasojejunal (NJ) tubes
NJ tubes are commonly used for short-term feeding when it is desirable to bypass the stomach, for example, in the treatment of patients suffering pancreatitis. NJ tubes are normally placed, and their positioning checked, in the radiology department. It is common practice to feed for up to 24 hours when feeding into the bowel as a break is not required. Continuous feeding is sometimes necessary, as larger volumes of feed are generally not tolerated, leading to diarrhoea and patient discomfort. If at any time during feeding the patient shows any unusual signs of shortness of breath, sudden pallor and/or increased heart rate, then the feeding shouid be stopped immediately and medicai staff contacted urgently. 
Jejunostomy tubes
Jejunostomy tubes are placed as a long-term solution to ETF when bypassing the upper gastrointestinal tract is indicated. They are normally placed at laparotomy under general anaesthesia. For this reason, as well as the narrow lumen of the tubes, great care should be taken in maintaining tube patency. Although it is common practice in NHS Trust nutritional support guidelines to recommend that jejunostomy tubes should be flushed every 4 hours, as it is thought that this may help prevent blockages of the narrow lumen, it is difficult to find any concrete evidence to support this practice. However, as frequent flushing may be necessary to provide adequate amounts of fluids and should not interfere with either the patient's care nor comfort, it does seem sensible to maintain this recommendation.
Diarrhoea can also be a problem and can necessitate regular medication, such as loperamide or co-codamol. For this reason, it is usually recommended that patients use a feed without fibre, although very occasionally patients may also experience constipation with a jejunostomy tube. As with an NJ tube, bolus feeding and high feeding rates are not normally tolerated. Large water flushes (>200 ml) should probably not be used as necrotizing enteritis has been reported with 400 ml water flushes (Schloerb et al, 2004) .
Gastrostomy tubes
By far the most common type of long-term ETF device, gastrostomy tubes are usually placed endoscopically. Gastrostomy tubes have both an internal and an external fixator, although some low-profile balloon gastrostomy devices do not have external fixators. For the first 14-21 days post-gastrostomy-tube insertion, the external fixation device should be left undisturbed to allow a stoma tract to form (Clinical Resource Efficiency Support Team, 2004) . The skin around the stoma site and under the retention device should be cleaned daily with sterile water or saline using lint-free gauze. The skin should then be thoroughly dried. After 14-21 days post-gastrostomy-tube insertion, the stoma should be cleaned daily (Department of Health, 2006) with lint-free gauze or a clean flannel and a mild solution of soapy water or sterile water and rinsed working in a circular motion from the centre of the stoma outwards. The PEG site should then be dried thoroughly.
The external fixation device should be released regularly to clean the skin around the stoma site thoroughly and the tube should be advanced and rotated before replacing the external fixation device. This procedure is thought to prevent what is known as 'buried bumper syndrome', a condition where the internal fixator becomes embedded in the gastric mucosa. The procedure involves rotating the tube a full 360 degrees and advancing it 2-3 cm into the tract (Fresenius Kabi, 2000) .The tube should then be pulled back to rest against the internal gastric wall without pulling it back too tight to prevent ulceration ofthe gastric mucosa. This procedure should be carried out at least weekly, but no more often than daily (Fresenius Kabi, 2000) , depending on local policy and individual manufacturers' guidance. The external fixation device should then be replaced to lie 0.2-0.5 cm away from the abdominal wall.
Conclusion
ETF is a valuable tool in the care and management of a variety of patients in the acute care setting. Many will require only short-term ETF and for such patients, clear guidelines and knowledge on managing ETF will provide consistent and safe patient care. DB
